Drug Targeting Organ-Specific Strategies
Drug Targeting Organ-Specific Strategies
Drug Targeting Organ-Specific Strategies
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
e<br />
E. coli expression system 292<br />
effectiveness of drug targeting 141, 357,<br />
363<br />
endocytosis (receptor mediated) 8, 108,<br />
191<br />
– cytoplasmic delivery 9<br />
– in the brain 30<br />
– Kupffer cells 94, 108<br />
– mitochondrial targeting 10<br />
– nuclear targeting 9<br />
– sinusoidal endothelial cells 92, 108<br />
endoglin (targeting) 241, 245<br />
endothelial cells<br />
– activation 177<br />
– activation inhibition 182<br />
– angiogenic vasculature 181, 233, 265<br />
– brain endothelium 27, 34<br />
– inflammatory endothelial cells 172, 177,<br />
179<br />
– in vitro assays 34, 187, 238<br />
– markers of 241<br />
– sources 237<br />
– sinusoidal endothelial cells 91, 93, 100<br />
– pulmonary endothelial cells 17, 181<br />
– tumor vasculature 17, 233, 241, 249, 265,<br />
266<br />
expression systems 292, 296<br />
f<br />
fibrosis<br />
– kidney 150<br />
– liver 96, 98<br />
folate<br />
– as homing device 281<br />
– pro-drug approach 134<br />
formulations for pulmonary delivery 67<br />
fungal expression system 293<br />
g<br />
galactose receptors 91, 94, 114<br />
gene therapy 9, 16, 221<br />
– brain targeting 48<br />
– nuclear targeting 9<br />
– pharmacokinetic considerations 362<br />
– pulmonary delivery/targeting 54, 81<br />
glomerulonephritis 150<br />
γ-glutamyl pro-drug approach 133<br />
h<br />
HDL, see lipoproteins<br />
hepatic stellate cells 95<br />
hepatocytes 91, 309, 318, 365<br />
HIV, drug targeting to 46, 282, 301, 365<br />
HIV, infection 25, 373<br />
homing device 279<br />
HPMA, see polymers, soluble 5<br />
human tissue slices, see tissue slices<br />
i<br />
immunogenicity of drug targeting therapies<br />
18, 210, 222, 268<br />
immunoliposomes, see liposomes<br />
immune response 16, 25, 160, 171<br />
immunotherapy of cancer 209, 216, 224,<br />
226, 227<br />
immunotoxins 213, 223, 245, 246, 298,<br />
300<br />
inflammation 171<br />
– and angiogenesis 175, 186, 234<br />
– apoptosis in, see apoptosis<br />
– in brain diseases 25<br />
– inflammatory bowel disease 159, 174<br />
– rheumatoid arthritis 173, 177<br />
– kidney 124, 148<br />
– liver 89, 93, 94, 96, 323<br />
– role of NFκB 97, 105, 174, 178<br />
– atherosclerosis 174, 177<br />
inflammatory bowel disease (IBD), see also<br />
inflammation 174, 177<br />
– animal models, see animal models<br />
(of disease)<br />
– bowel pH 162<br />
– colonic delivery 160<br />
inhalation therapy 53<br />
– dry powder inhalation 73<br />
– formulations for 67<br />
inhaler<br />
– dry powder inhaler 63, 65<br />
– nebulizer 63, 64<br />
– (pressurized) metered dose inhaler 63,<br />
65<br />
insulin receptor targeting 30, 42<br />
integrin targeting 181, 246<br />
integrins, see also angiogenesis 180, 236<br />
internalization, see endocytosis<br />
intestines, see colon<br />
intracelluar routing, see endocytosis<br />
k<br />
kidney 121<br />
– animal models, see animal models<br />
(of disease)<br />
– cells of the 123<br />
– diseases of the 124<br />
– drug targeting to 124, 135<br />
– in vitro models 149<br />
– tissue slices 327<br />
– renal catabolism of LMWP 139<br />
Krumdieck slicer 310, 312<br />
Kupffer cells 93, 100<br />
l<br />
LDL, see lipoproteins<br />
leukaemia 200, 222<br />
linkage between drug and carrier, see conjugation<br />
techniques<br />
Index 379